The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome

NCT04912934 | Completed

• 1 other identifier: KAEK-228
• Study Type: observational
• Target: 214
• Locations: 1 country
• Sites: 1

Brief Summary

The aim was to determine the coronavirus anxiety levels and emotional eating status of cases with diagnosis of MetS according to diagnostic criteria published by the International Diabetic Federation (IDF) in 2005 and healthy individuals with similar BMI to MetS subjects.

Conditions

Metabolic Syndrome; Emotional Eating; COVID-19

Keywords

Metabolic Syndrome; COVID-19; Eating

Outcome Measures

Primary Outcomes (2)

• Coronavirus anxiety scale (CAS)

  Total points of ≥9 on the scale shows dysfunctional anxiety related to coronavirus.

  5 month

• Emotional eating scale (EES)

  High points on the scale show high levels of emotional eating behavior.

  5 month.

Secondary Outcomes (11)

• BMI (Body Mass Index)

  5 month.

• Glucose

  5 month.

• Blood pressure

  5 month.

• HDL

  5 month.

• LDL

  5 month.

Study Arms (2)

MetS diagnosis

The research included individuals aged 18 years and older, who were not pregnant or breastfeeding, without any psychological disorder diagnosed by psychiatry, without diagnosis of COVID-19 and not using any psychiatric medications. The MetS group for the research included individuals with metabolic syndrome diagnosis according to IDF-2005 diagnostic criteria.

Procedure: A survey form was applied to individuals included in the study face-to-face.

non-MetS

The research included individuals aged 18 years and older, who were not pregnant or breastfeeding, without any psychological disorder diagnosed by psychiatry, without diagnosis of COVID-19 and not using any psychiatric medications. The non MetS group in the research included healthy individuals not using any psychiatric medications, without any chronic disorder, and with similar BMI to the individuals in the subject group.

Procedure: A survey form was applied to individuals included in the study face-to-face.

Interventions

A survey form was applied to individuals included in the study face-to-face. PROCEDURE

This study was completed with a descriptive, cross-sectional and relational screening model

Also known as: This survey form, Biochemical findings (glucose, HDL, LDL, total cholesterol, triglycerides, CRP, HbA1c, insulin, HOMA-IR)., Blood pressure was measured and recorded., The coronavirus anxiety scale (CAS) and emotional eating scale (EES) were applied.

MetS diagnosis; non-MetS

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Power analysis was performed using the G\*Power (v3.1.9) program to determine the number of samples. According to Jacob Cohen's effect size coefficients, it was calculated that there should be at least 105 people in the groups for α=0.05 and 1-β=0.95 (95% power) levels, assuming that the evaluations between the two independent groups would have a medium effect size (d=0.5).

You may qualify if:

• The research included individuals aged 18 years and older, who were not pregnant or breastfeeding, without any psychological disorder diagnosed by psychiatry, without diagnosis of COVID-19 and not using any psychiatric medications. The MetS group for the research included individuals with metabolic syndrome diagnosis according to IDF-2005 diagnostic criteria. The non MetS group in the research included healthy individuals not using any psychiatric medications, without any chronic disorder, and with similar BMI to the individuals in the subject group.

You may not qualify if:

• The research included individuals aged 18 years and older, who were pregnant or breastfeeding, with psychological disorder diagnosed by psychiatry, with diagnosis of COVID-19 and using psychiatric medications.

Sponsors & Collaborators

• Ordu University: lead

Study Sites (1)

Dilek alemdar

Ordu, 52000, Turkey (Türkiye)

Location

Related Publications (1)

• Zhang J, Zhang Y, Huo S, Ma Y, Ke Y, Wang P, Zhao A. Emotional Eating in Pregnant Women during the COVID-19 Pandemic and Its Association with Dietary Intake and Gestational Weight Gain. Nutrients. 2020 Jul 28;12(8):2250. doi: 10.3390/nu12082250.

  PMID: 32731389 BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

glucose, HDL, LDL, total cholesterol, triglycerides, CRP, HbA1c, insulin, HOMA-IR

MeSH Terms

Conditions

Metabolic Syndrome; Emotional Eating; COVID-19

Interventions

Glucose; oxidized low density lipoprotein; Cholesterol; Triglycerides; Insulin

Condition Hierarchy (Ancestors)

Insulin Resistance; Hyperinsulinism; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Feeding Behavior; Behavior; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Hexoses; Monosaccharides; Sugars; Carbohydrates; Cholestenes; Cholestanes; Steroids; Fused-Ring Compounds; Polycyclic Compounds; Sterols; Membrane Lipids; Lipids; Glycerides; Proinsulin; Insulins; Pancreatic Hormones; Peptide Hormones; Hormones; Hormones, Hormone Substitutes, and Hormone Antagonists; Peptides; Amino Acids, Peptides, and Proteins

Study Officials

• Dilek Küçük Alemdar

  Ordu University

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: May 30, 2021
• First Posted: June 3, 2021
• Study Start: June 20, 2020
• Primary Completion: November 20, 2020
• Study Completion: December 12, 2020
• Last Updated: June 3, 2021

Record last verified: 2021-06

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)